290650.KQ
엘앤씨바이오
KOE · Healthcare · Medical - Specialties · KR
KRW 25,100.00
+0.60%Year over year
Reported trailing growth
- Revenue
- +53.1%
- EBITDA
- -88.9%
- EBIT
- +1825.9%
- EPS
- —
- Free cash flow
- +36.3%
- Operating cash flow
- +3235.2%
Forward estimates
Based on analyst estimates
- Revenue
- +52.4%
- EBITDA
- +355.9%
- EPS
- +132.3%
Three-year CAGR
- Revenue
- +17.6%
- EBITDA
- -3.7%
- EBIT
- -28.7%
- Net income
- —
- EPS
- —
- Free cash flow
- +76.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026